The invention relates to a thermoformed, tamper-resistant pharmaceutical dosage form comprising a) a pharmacologically active ingredient b) a polyalkylene oxide having a weight average molecular weight of more than 200,000 g/mol and c) a zinc component, wherein the content of said zinc component is at least 1 ppm, relative to the total weight of the pharmaceutical dosage form.
